BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 856358)

  • 21. Studies of human peripheral lymph. II. Low lymphocyte count and few B-lymphocytes in peripheral lymph of patients with chronic lymphocytic leukaemia.
    Engeset A; Froland SS; Bremer K
    Scand J Haematol; 1974; 13(2):93-100. PubMed ID: 4547504
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum immunoglobulins and lymphocyte subsets in chronic lymphocytic leukemia.
    Davey FR; Kurec AS; Tomar RH; Smith JR
    Am J Clin Pathol; 1987 Jan; 87(1):60-5. PubMed ID: 2948384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia.
    Pizzolo G; Chilosi M; Ambrosetti A; Semenzato G; Fiore-Donati L; Perona G
    Blood; 1983 Dec; 62(6):1289-96. PubMed ID: 6357309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat production by lymphocytes in chronic lymphocytic leukaemia.
    Brandt L; Ikomi-Kumm J; Monti M; Wadsö I
    Scand J Haematol; 1979 Feb; 22(2):141-4. PubMed ID: 432550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Prolymphocytoid' transformation of chronic lymphocytic leukaemia.
    Enno A; Catovsky D; O'Brien M; Cherchi M; Kumaran TO; Galton DA
    Br J Haematol; 1979 Jan; 41(1):9-18. PubMed ID: 420739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte membrane receptors in human lymphoid leukemias.
    Ferrarini M; Tonda GP; Risso A; Viale G
    Eur J Immunol; 1975 Feb; 5(2):89-93. PubMed ID: 135682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and cell surface marker characterization of the early phase of chronic lymphocytic leukemia.
    Rudders RA; Howard JP
    Blood; 1978 Jul; 52(1):25-35. PubMed ID: 306844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance.
    Montserrat E; Sanchez-Bisono J; Viñolas N; Rozman C
    Br J Haematol; 1986 Mar; 62(3):567-75. PubMed ID: 3954968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte doubling time in chronic lymphocytic leukemia: an update of its prognostic significance.
    Viñolas N; Reverter JC; Urbano-Ispizua A; Montserrat E; Rozman C
    Blood Cells; 1987; 12(2):457-70. PubMed ID: 3620708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No evidence of a lymphocytopenic state before manifestation of chronic lymphocytic leukemia.
    Björkholm M; Grimfors G; Kimby E; Holm G
    Acta Med Scand; 1984; 215(4):371-4. PubMed ID: 6731046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total tumour mass score (TTM): a new parameter in chronic lymphocyte leukaemia.
    Jaksić B; Vitale B
    Br J Haematol; 1981 Nov; 49(3):405-13. PubMed ID: 7295587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B-chronic lymphocytic leukaemia patients with stable benign disease show a distinctive membrane phenotype.
    Caligaris-Cappio F; Gobbi M; Bergui L; Campana D; Lauria F; Fierro MT; Foa R
    Br J Haematol; 1984 Apr; 56(4):655-60. PubMed ID: 6370298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia.
    Molica S; Alberti A
    Cancer; 1987 Dec; 60(11):2712-6. PubMed ID: 3677006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathology of large granular lymphocyte leukemia.
    Agnarsson BA; Loughran TP; Starkebaum G; Kadin ME
    Hum Pathol; 1989 Jul; 20(7):643-51. PubMed ID: 2661408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia.
    Mendelsohn J; Nordberg J
    J Clin Invest; 1979 Jun; 63(6):1124-32. PubMed ID: 221534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B lymphocyte function in B cell chronic lymphocytic leukaemia.
    Wolos JA; Davey FR
    Br J Haematol; 1981 Nov; 49(3):395-403. PubMed ID: 6457623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lymphocytic leukemia: studies on the effect of drug treatment on different lymphocytic subpopulations.
    Salsano F; Froland SS; Natvig JB; Mandelli F
    Scand J Immunol; 1976; 5(10):1185-90. PubMed ID: 1087747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
    Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
    Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enumeration of absolute numbers of T lymphocyte subsets in B-chronic lymphocytic leukaemia using an immunoperoxidase technique: relation to clinical stage.
    Markey GM; Alexander HD; Agnew AN; McConnell RE; Morris TC; Robertson JH; Crockard AD; Bridges JM
    Br J Haematol; 1986 Feb; 62(2):257-73. PubMed ID: 3511946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.